Dr. Panda's Newsletter

Share this post

User's avatar
Dr. Panda's Newsletter
Is Pepto-Bismol the next COVID 'cure'?

Is Pepto-Bismol the next COVID 'cure'?

Procter & Gamble thinks so

Dr Panda's avatar
Dr Panda
Dec 03, 2022
∙ Paid
82

Share this post

User's avatar
Dr. Panda's Newsletter
Is Pepto-Bismol the next COVID 'cure'?
44
Share
Long-sought structure of Pepto-Bismol decoded

Good Morning!

Pepto-Bismol may be the cure for COVID. The University of Louisville and Procter & Gamble (P&G) are currently recruiting for a clinical trial using Pepto-Bismol (oral bismuth subsalicylate, or BSS) as a potential antiviral to SARS-CoV-2.

Here’s What We Know

Pepto-Bismol was first sold in the United States as a remedy for infant diarrhea arou…

Keep reading with a 7-day free trial

Subscribe to Dr. Panda's Newsletter to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Dr. Panda
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share